1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Ophthalmic Therapeutic Drugs Revenue
1.4 Market by Type
1.4.1 Global Ophthalmic Therapeutic Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Anti-inflammatory Drugs
1.4.3 Anti-infective Drugs
1.4.4 Anti-glaucoma Drugs
1.4.5 Anti-allergy Drugs
1.4.6 Anti-VEGF Agents
1.4.7 Others
1.5 Market by Application
1.5.1 Global Ophthalmic Therapeutic Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Online Pharmacies
1.5.4 Independent Pharmacies & Drug Stores
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Ophthalmic Therapeutic Drugs Market Perspective (2015-2026)
2.2 Global Ophthalmic Therapeutic Drugs Growth Trends by Regions
2.2.1 Ophthalmic Therapeutic Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Ophthalmic Therapeutic Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Ophthalmic Therapeutic Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Ophthalmic Therapeutic Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Ophthalmic Therapeutic Drugs Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Ophthalmic Therapeutic Drugs Players by Market Size
3.1.1 Global Top Ophthalmic Therapeutic Drugs Players by Revenue (2015-2020)
3.1.2 Global Ophthalmic Therapeutic Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Ophthalmic Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Ophthalmic Therapeutic Drugs Market Concentration Ratio
3.2.1 Global Ophthalmic Therapeutic Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Ophthalmic Therapeutic Drugs Revenue in 2019
3.3 Ophthalmic Therapeutic Drugs Key Players Head office and Area Served
3.4 Key Players Ophthalmic Therapeutic Drugs Product Solution and Service
3.5 Date of Enter into Ophthalmic Therapeutic Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Ophthalmic Therapeutic Drugs Historic Market Size by Type (2015-2020)
4.2 Global Ophthalmic Therapeutic Drugs Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020)
5.2 Global Ophthalmic Therapeutic Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Ophthalmic Therapeutic Drugs Market Size (2015-2020)
6.2 Ophthalmic Therapeutic Drugs Key Players in North America (2019-2020)
6.3 North America Ophthalmic Therapeutic Drugs Market Size by Type (2015-2020)
6.4 North America Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020)
7 Europe
7.1 Europe Ophthalmic Therapeutic Drugs Market Size (2015-2020)
7.2 Ophthalmic Therapeutic Drugs Key Players in Europe (2019-2020)
7.3 Europe Ophthalmic Therapeutic Drugs Market Size by Type (2015-2020)
7.4 Europe Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020)
8 China
8.1 China Ophthalmic Therapeutic Drugs Market Size (2015-2020)
8.2 Ophthalmic Therapeutic Drugs Key Players in China (2019-2020)
8.3 China Ophthalmic Therapeutic Drugs Market Size by Type (2015-2020)
8.4 China Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020)
9 Japan
9.1 Japan Ophthalmic Therapeutic Drugs Market Size (2015-2020)
9.2 Ophthalmic Therapeutic Drugs Key Players in Japan (2019-2020)
9.3 Japan Ophthalmic Therapeutic Drugs Market Size by Type (2015-2020)
9.4 Japan Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Ophthalmic Therapeutic Drugs Market Size (2015-2020)
10.2 Ophthalmic Therapeutic Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Ophthalmic Therapeutic Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020)
11 India
11.1 India Ophthalmic Therapeutic Drugs Market Size (2015-2020)
11.2 Ophthalmic Therapeutic Drugs Key Players in India (2019-2020)
11.3 India Ophthalmic Therapeutic Drugs Market Size by Type (2015-2020)
11.4 India Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Ophthalmic Therapeutic Drugs Market Size (2015-2020)
12.2 Ophthalmic Therapeutic Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Ophthalmic Therapeutic Drugs Market Size by Type (2015-2020)
12.4 Central & South America Ophthalmic Therapeutic Drugs Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bayer
13.1.1 Bayer Company Details
13.1.2 Bayer Business Overview
13.1.3 Bayer Ophthalmic Therapeutic Drugs Introduction
13.1.4 Bayer Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020))
13.1.5 Bayer Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Ophthalmic Therapeutic Drugs Introduction
13.2.4 Pfizer Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Ophthalmic Therapeutic Drugs Introduction
13.3.4 Novartis Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 ALLERGAN
13.4.1 ALLERGAN Company Details
13.4.2 ALLERGAN Business Overview
13.4.3 ALLERGAN Ophthalmic Therapeutic Drugs Introduction
13.4.4 ALLERGAN Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020)
13.4.5 ALLERGAN Recent Development
13.5 Aerie Pharmaceuticals
13.5.1 Aerie Pharmaceuticals Company Details
13.5.2 Aerie Pharmaceuticals Business Overview
13.5.3 Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Introduction
13.5.4 Aerie Pharmaceuticals Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020)
13.5.5 Aerie Pharmaceuticals Recent Development
13.6 Bausch Health
13.6.1 Bausch Health Company Details
13.6.2 Bausch Health Business Overview
13.6.3 Bausch Health Ophthalmic Therapeutic Drugs Introduction
13.6.4 Bausch Health Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020)
13.6.5 Bausch Health Recent Development
13.7 Genentech
13.7.1 Genentech Company Details
13.7.2 Genentech Business Overview
13.7.3 Genentech Ophthalmic Therapeutic Drugs Introduction
13.7.4 Genentech Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020)
13.7.5 Genentech Recent Development
13.8 Regeneron Pharmaceuticals
13.8.1 Regeneron Pharmaceuticals Company Details
13.8.2 Regeneron Pharmaceuticals Business Overview
13.8.3 Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Introduction
13.8.4 Regeneron Pharmaceuticals Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020)
13.8.5 Regeneron Pharmaceuticals Recent Development
13.9 Takeda
13.9.1 Takeda Company Details
13.9.2 Takeda Business Overview
13.9.3 Takeda Ophthalmic Therapeutic Drugs Introduction
13.9.4 Takeda Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020)
13.9.5 Takeda Recent Development
13.10 Santen Pharmaceutical
13.10.1 Santen Pharmaceutical Company Details
13.10.2 Santen Pharmaceutical Business Overview
13.10.3 Santen Pharmaceutical Ophthalmic Therapeutic Drugs Introduction
13.10.4 Santen Pharmaceutical Revenue in Ophthalmic Therapeutic Drugs Business (2015-2020)
13.10.5 Santen Pharmaceutical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
【掲載企業】
Bayer、Pfizer、Novartis、ALLERGAN、Aerie Pharmaceuticals、Bausch Health、Genentech、Regeneron Pharmaceuticals、Takeda、Santen Pharmaceutical
【免責事項】
https://www.globalresearch.jp/disclaimer